Nuveen’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.4M | Sell |
289,325
-149,032
| -34% | -$16.2M | 0.01% | 789 |
|
|
2026
Q1 | $40.5M | Sell |
438,357
-35,094
| -7% | -$3.52M | 0.01% | 747 |
|
|
2025
Q4 | $48.4M | Buy |
473,451
+18,492
| +4% | +$1.65M | 0.01% | 658 |
|
|
2025
Q3 | $28.4M | Buy |
454,959
+8,350
| +2% | +$454K | 0.01% | 922 |
|
|
2025
Q2 | $23.2M | Buy |
446,609
+371,783
| +497% | +$16.6M | 0.01% | 1008 |
|
|
2025
Q1 | $3.15M | Sell |
74,826
-246,416
| -77% | -$10.6M | ﹤0.01% | 2148 |
|
|
2024
Q4 | $9.81M | Sell |
321,242
-90,508
| -22% | -$2.55M | ﹤0.01% | 1614 |
|
|
2024
Q3 | $9.45M | Sell |
411,750
-897,969
| -69% | -$25.4M | ﹤0.01% | 1647 |
|
|
2024
Q2 | $37.8M | Buy |
1,309,719
+492,210
| +60% | +$11.5M | 0.01% | 764 |
|
|
2024
Q1 | $16.9M | Sell |
817,509
-122,021
| -13% | -$2.62M | 0.01% | 1285 |
|
|
2023
Q4 | $25.4M | Buy |
939,530
+181,946
| +24% | +$4.77M | 0.01% | 993 |
|
|
2023
Q3 | $22.5M | Sell |
757,584
-25,763
| -3% | -$906K | 0.01% | 978 |
|
|
2023
Q2 | $28M | Buy |
783,347
+504,070
| +180% | +$14.5M | 0.01% | 863 |
|
|
2023
Q1 | $6.55M | Sell |
279,277
-201,937
| -42% | -$5.77M | ﹤0.01% | 1741 |
|
|
2022
Q4 | $13.1M | Sell |
481,214
-45,170
| -9% | -$2.07M | 0.01% | 1316 |
|
|
2022
Q3 | $28.3M | Sell |
526,384
-193,845
| -27% | -$9.95M | 0.01% | 796 |
|
|
2022
Q2 | $29.1M | Sell |
720,229
-1,003,327
| -58% | -$49.7M | 0.01% | 800 |
|
|
2022
Q1 | $99.4M | Sell |
1,723,556
-288,576
| -14% | -$19.7M | 0.03% | 419 |
|
|
2021
Q4 | $201M | Sell |
2,012,132
-259,271
| -11% | -$26.8M | 0.06% | 274 |
|
|
2021
Q3 | $284M | Buy |
2,271,403
+142,210
| +7% | +$16.9M | 0.09% | 213 |
|
|
2021
Q2 | $264M | Sell |
2,129,193
-179,459
| -8% | -$24.1M | 0.08% | 235 |
|
|
2021
Q1 | $352M | Buy |
2,308,652
+242,682
| +12% | +$36.7M | 0.11% | 171 |
|
|
2020
Q4 | $266M | Sell |
2,065,970
-813,974
| -28% | -$93.7M | 0.09% | 203 |
|
|
2020
Q3 | $322M | Sell |
2,879,944
-117,813
| -4% | -$10.8M | 0.12% | 153 |
|
|
2020
Q2 | $243M | Buy |
2,997,757
+1,426,318
| +91% | +$115M | 0.1% | 197 |
|
|
2020
Q1 | $109M | Buy |
1,571,439
+154,824
| +11% | +$11.9M | 0.05% | 288 |
|
|
2019
Q4 | $111M | Sell |
1,416,615
-4,203
| -0.3% | -$303K | 0.04% | 384 |
|
|
2019
Q3 | $90.7M | Buy |
1,420,818
+187,152
| +15% | +$16.5M | 0.04% | 421 |
|
|
2019
Q2 | $107M | Buy |
+1,233,666
| New | +$94.2M | 0.04% | 408 |
|
Other funds holding GH
DTC
Nuveen's GH Position: Q2 2026 in Review
Nuveen reduced its Guardant Health (GH) stake by 34% in Q2 2026, selling an estimated $16.2M and leaving 289,325 shares worth $43.4M. The position accounts for 0.01% of the portfolio, ranked #789.
Nuveen first reported a position in GH in Q2 2019 and has held it in 29 quarters since. The position peaked at $352M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Nuveen held 289,325 shares of Guardant Health worth $43.4M as of Q2 2026.
- Nuveen sold 149,032 Guardant Health shares in Q2 2026, an estimated $16.2M.
- Guardant Health made up 0.01% of Nuveen's portfolio in Q2 2026, its #789 holding.
- Nuveen first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
- Nuveen's Guardant Health position peaked at $352M in Q1 2021.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.